Detalhe da pesquisa
1.
Meningococcal ACWYX Conjugate Vaccine in 2-to-29-Year-Olds in Mali and Gambia.
N Engl J Med
; 388(21): 1942-1955, 2023 May 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-37224196
2.
Vaccines to Prevent Meningitis: Historical Perspectives and Future Directions.
Microorganisms
; 9(4)2021 Apr 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33917003
3.
Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870.
J Exp Med
; 197(6): 789-99, 2003 Mar 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-12642606
4.
Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit sera.
Infect Immun
; 77(2): 764-9, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19047406
5.
Evaluation of strain coverage of the multicomponent meningococcal serogroup B vaccine (4CMenB) administered in infants according to different immunisation schedules.
Hum Vaccin Immunother
; 15(3): 725-731, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30352000
6.
Fine antigenic specificity and cooperative bactericidal activity of monoclonal antibodies directed at the meningococcal vaccine candidate factor h-binding protein.
Infect Immun
; 76(9): 4232-40, 2008 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-18591239
7.
Breadth of coverage against a panel of 110 invasive disease isolates, immunogenicity and safety for 2 and 3 doses of an investigational MenABCWY vaccine in US adolescents - Results from a randomized, controlled, observer-blind phase II study.
Vaccine
; 36(35): 5309-5317, 2018 08 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-30061029
8.
Immune Responses to Booster Vaccination With Meningococcal ABCWY Vaccine After Primary Vaccination With Either Investigational or Licensed Vaccines: A Phase 2 Randomized Study.
Pediatr Infect Dis J
; 37(5): 475-482, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29329168
9.
Persistence of the immune response after MenACWY-CRM vaccination and response to a booster dose, in adolescents, children and infants.
Hum Vaccin Immunother
; 12(5): 1300-10, 2016 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-26829877
10.
Persistence of group C anticapsular antibodies two to three years after immunization with an investigational quadrivalent Neisseria meningitidis-diphtheria toxoid conjugate vaccine.
Pediatr Infect Dis J
; 24(2): 132-6, 2005 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-15702041
11.
Immunogenicity and safety of a novel quadrivalent meningococcal conjugate vaccine (MenACWY-CRM) in healthy Korean adolescents and adults.
Int J Infect Dis
; 28: 204-10, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25316331
12.
Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activity.
Clin Vaccine Immunol
; 16(6): 785-91, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19339487
13.
Factor H and neisserial pathogenesis.
Vaccine
; 26 Suppl 8: I40-5, 2008 Dec 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-19388163
14.
Complement-dependent synergistic bactericidal activity of antibodies against factor H-binding protein, a sparsely distributed meningococcal vaccine antigen.
J Infect Dis
; 197(7): 1053-61, 2008 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18419542
15.
Immunity to Neisseria meningitidis group B in adults despite lack of serum bactericidal antibody.
Clin Vaccine Immunol
; 14(12): 1596-602, 2007 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-17913865
16.
Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870.
Vaccine
; 25(10): 1912-20, 2007 Feb 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-16677743
17.
Prevalence of factor H-binding protein variants and NadA among meningococcal group B isolates from the United States: implications for the development of a multicomponent group B vaccine.
J Infect Dis
; 195(10): 1472-9, 2007 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17436227
18.
Antibody persistence 3 years after immunization of adolescents with quadrivalent meningococcal conjugate vaccine.
J Infect Dis
; 193(6): 821-8, 2006 Mar 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-16479517
19.
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance.
J Immunol
; 177(1): 501-10, 2006 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16785547
20.
Role of FNR and FNR-regulated, sugar fermentation genes in Neisseria meningitidis infection.
Mol Microbiol
; 60(4): 963-72, 2006 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-16677307